US2021169082A1PendingUtilityA1
Antibacterial surface of metal-organic framework-chitosan composite films
Assignee: UNIV COLORADO STATE RES FOUNDPriority: Jul 11, 2017Filed: Jul 11, 2018Published: Jun 10, 2021
Est. expiryJul 11, 2037(~10.9 yrs left)· nominal 20-yr term from priority
A61L 2103/15A61L 2101/34A61L 2101/42A61L 2/18A01N 25/10C08K 5/56A01N 43/16A01N 55/02C08B 37/003A01N 59/20A61L 2/23
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A substrate having an antibacterial surface includes a chitosan matrix and water-stable metal-organic frameworks dispersed throughout the chitosan matrix. The water-stable metal-organic frame-works are present in an amount of 5% wt/wt to 20% wt/wt based on total solids of the substrate
Claims
exact text as granted — not AI-modifiedThe following is claimed:
1 . A substrate having an antibacterial surface, the substrate comprising:
a chitosan matrix; and water-stable metal-organic frameworks dispersed throughout the chitosan matrix, the water-stable metal-organic frameworks present in an amount of 5% wt/wt to 20% wt/wt based on total solids of the substrate.
2 . The substrate of claim 1 , wherein the water-stable metal-organic frameworks are copper-based, water-stable metal organic frameworks.
3 . The substrate of claim 1 , wherein the water-stable metal-organic frameworks are H 3 [(Cu 4 Cl) 3 —(BTTri) 8 ] (H 3 BTTri=1,3,5-tris(1H-1,2,3-triazol-5-yl)benzene).
4 . The substrate of claim 1 , wherein the water-stable metal-organic frameworks are crystalline after 72 hours in a nutrient broth media.
5 . The substrate of claim 1 , wherein the substrate is a biomedical substrate.
6 . The substrate of claim 1 , wherein the water-stable metal-organic frameworks present in an amount of 5% wt/wt based on total solids of the substrate.
7 . A method of making a substrate having an antibacterial surface, the method comprising:
dispersing water-stable metal-organic frameworks in a chitosan matrix to form a water-soluble chitosan/water-stable metal-organic framework material, the water-stable metal-organic frameworks present in the water-soluble chitosan/water-stable metal-organic framework material in an amount of 5% wt/wt to 20% wt/wt based on total solids of the material; and converting the water-soluble chitosan/water-stable metal-organic framework material to a water-insoluble chitosan/water-stable copper-based metal-organic framework material with a buffer solution.
8 . The method of claim 7 , wherein the water-stable metal-organic frameworks are copper-based, water-stable metal organic frameworks.
9 . The method of claim 7 , wherein the water-stable metal-organic frameworks are H 3 [(Cu 4 Cl) 3 —(BTTri) 8 ] (H 3 BTTri=1,3,5-tris(1H-1,2,3-triazol-5-yl)benzene).
10 . The method of claim 7 , wherein the water-stable metal-organic frameworks are crystalline after 72 hours in a nutrient broth media.
11 . The method of claim 7 , and further comprising forming the water-insoluble chitosan/water-stable copper-based metal-organic framework material into a biomedical device.
12 . The method of claim 7 , wherein the water-stable metal-organic frameworks present in an amount of 5% wt/wt based on total solids of the substrate.
13 . A method of using a material to reduce adhesion of bacteria on a surface of the material, the method comprising:
exposing the material comprising copper-based metal-organic frameworks dispersed throughout a chitosan matrix to a solution containing the bacteria, wherein during the exposure the material reduces bacterial adhesion by at least 85% in the first six hours of exposure as compared to material that does not include the copper-based metal-organic frameworks and wherein after the first six hours of exposure the material does not release copper in a bactericidal effective amount.
14 . The method of using the material of claim 13 , and further comprising:
removing the material from exposure to the bacteria; sterilizing the material after the removing step; and exposing the material to a new environment of bacterial after the sterilizing step, wherein during the second exposing step the material reduces bacterial adhesion by at least 85% in the first six hours of exposure as compared to material that does not include the copper-based metal-organic frameworks and wherein the material is not subject to regeneration before the second exposing step.
15 . The method of claim 13 wherein the bacteria is Pseudomonas aeruginosa.Join the waitlist — get patent alerts
Track US2021169082A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.